MARATTO

erratum · Neuropharmacology

Corrigendum to “Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways” [Neuropharmacol. (2021) 1, 197, 108738]

2024Ain Shams University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Nicotinic Acetylcholine Receptors Study
  • Nanoplatforms for cancer theranostics
  • Cancer-related cognitive impairment studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.neuropharm.2024.109989

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.